American Money Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $279K | Hold |
11,605
| – | – | 0.04% | 147 |
|
|
2026
Q1 | $326K | Sell |
11,605
-665
| -5% | -$17.7K | 0.05% | 131 |
|
|
2025
Q4 | $306K | Buy |
+12,270
| New | +$309K | 0.05% | 132 |
|
|
2025
Q1 | – | Sell |
-7,946
| Closed | -$211K | – | 138 |
|
|
2024
Q4 | $211K | Buy |
+7,946
| New | +$216K | 0.04% | 136 |
|
|
2024
Q2 | – | Sell |
-9,848
| Closed | -$273K | – | 139 |
|
|
2024
Q1 | $273K | Buy |
9,848
+3
| +0% | +$83 | 0.06% | 125 |
|
|
2023
Q4 | $283K | Sell |
9,845
-1,339
| -12% | -$40.5K | 0.06% | 119 |
|
|
2023
Q3 | $371K | Sell |
11,184
-626
| -5% | -$22.1K | 0.09% | 103 |
|
|
2023
Q2 | $433K | Buy |
11,810
+412
| +4% | +$16K | 0.11% | 101 |
|
|
2023
Q1 | $465K | Sell |
11,398
-807
| -7% | -$34.9K | 0.12% | 97 |
|
|
2022
Q4 | $625K | Buy |
12,205
+502
| +4% | +$24.1K | 0.18% | 83 |
|
|
2022
Q3 | $512K | Buy |
11,703
+2
| +0% | +$97 | 0.16% | 86 |
|
|
2022
Q2 | $614K | Buy |
11,701
+1
| +0% | +$51 | 0.18% | 81 |
|
|
2022
Q1 | $606K | Sell |
11,700
-685
| -6% | -$35.5K | 0.16% | 90 |
|
|
2021
Q4 | $731K | Sell |
12,385
-41
| -0.3% | -$2.03K | 0.19% | 82 |
|
|
2021
Q3 | $534K | Buy |
12,426
+2,586
| +26% | +$115K | 0.15% | 97 |
|
|
2021
Q2 | $385K | Sell |
9,840
-76,697
| -89% | -$2.98M | 0.13% | 70 |
|
|
2021
Q1 | $3.13M | Sell |
86,537
-3,882
| -4% | -$138K | 1.17% | 40 |
|
|
2020
Q4 | $3.33M | Sell |
90,419
-7,578
| -8% | -$278K | 1.3% | 36 |
|
|
2020
Q3 | $3.41M | Sell |
97,997
-8,246
| -8% | -$289K | 1.55% | 31 |
|
|
2020
Q2 | $3.3M | Sell |
106,243
-1,133
| -1% | -$38.5K | 1.54% | 32 |
|
|
2020
Q1 | $3.33M | Buy |
107,376
+12,438
| +13% | +$424K | 1.86% | 17 |
|
|
2019
Q4 | $3.53M | Buy |
94,938
+70
| +0.1% | +$2.49K | 1.65% | 27 |
|
|
2019
Q3 | $3.23M | Sell |
94,868
-3,800
| -4% | -$138K | 1.73% | 26 |
|
|
2019
Q2 | $4.05M | Buy |
98,668
+1,648
| +2% | +$65.4K | 2.17% | 17 |
|
|
2019
Q1 | $3.91M | Sell |
97,020
-4,647
| -5% | -$186K | 2.17% | 15 |
|
|
2018
Q4 | $4.21M | Sell |
101,667
-1,289
| -1% | -$53.5K | 2.65% | 7 |
|
|
2018
Q3 | $4.3M | Buy |
102,956
+1,711
| +2% | +$65.9K | 2.47% | 10 |
|
|
2018
Q2 | $3.48M | Sell |
101,245
-1,341
| -1% | -$45.8K | 2.11% | 18 |
|
|
2018
Q1 | $3.45M | Buy |
102,586
+3,935
| +4% | +$135K | 2.16% | 18 |
|
|
2017
Q4 | $3.39M | Buy |
98,651
+14,056
| +17% | +$479K | 2.05% | 22 |
|
|
2017
Q3 | $2.87M | Buy |
84,595
+1,427
| +2% | +$45.9K | 1.9% | 27 |
|
|
2017
Q2 | $2.65M | Sell |
83,168
-1,289
| -2% | -$40.6K | 1.89% | 25 |
|
|
2017
Q1 | $2.74M | Buy |
84,457
+1,670
| +2% | +$52.7K | 2.02% | 22 |
|
|
2016
Q4 | $2.55M | Sell |
82,787
-4,427
| -5% | -$135K | 2.05% | 17 |
|
|
2016
Q3 | $2.8M | Buy |
87,214
+1,070
| +1% | +$35.8K | 2.24% | 12 |
|
|
2016
Q2 | $2.88M | Sell |
86,144
-3,343
| -4% | -$107K | 2.38% | 10 |
|
|
2016
Q1 | $2.52M | Buy |
89,487
+13,422
| +18% | +$383K | 2.08% | 17 |
|
|
2015
Q4 | $2.33M | Buy |
76,065
+7,510
| +11% | +$236K | 2% | 19 |
|
|
2015
Q3 | $2.04M | Sell |
68,555
-1,496
| -2% | -$48K | 1.93% | 23 |
|
|
2015
Q2 | $2.23M | Buy |
70,051
+9,237
| +15% | +$301K | 1.88% | 19 |
|
|
2015
Q1 | $2.01M | Sell |
60,814
-2,080
| -3% | -$66.1K | 1.75% | 25 |
|
|
2014
Q4 | $1.86M | Sell |
62,894
-1,718
| -3% | -$49.3K | 1.6% | 26 |
|
|
2014
Q3 | $1.81M | Buy |
64,612
+205
| +0.3% | +$5.75K | 1.54% | 27 |
|
|
2014
Q2 | $1.81M | Buy |
64,407
+3,866
| +6% | +$110K | 1.48% | 27 |
|
|
2014
Q1 | $1.84M | Buy |
60,541
+3,969
| +7% | +$118K | 1.57% | 21 |
|
|
2013
Q4 | $1.64M | Buy |
+56,572
| New | +$1.65M | 1.42% | 33 |
|
Other funds holding PFE
American Money Management's PFE Position: Q2 2026 in Review
American Money Management held its Pfizer (PFE) position steady in Q2 2026 at 11,605 shares worth $279K. The position accounts for 0.04% of the portfolio, ranked #147.
American Money Management first reported a position in PFE in Q4 2013 and has held it in 46 quarters since. The position peaked at $4.3M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- American Money Management held 11,605 shares of Pfizer worth $279K as of Q2 2026.
- American Money Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.04% of American Money Management's portfolio in Q2 2026, its #147 holding.
- American Money Management first reported a position in Pfizer in Q4 2013 and has held it in 46 quarters since.
- American Money Management's Pfizer position peaked at $4.3M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on American Money Management's 13F filing for Q2 2026, filed 13 Aug 2026.